The high cost of prescription drugs remains a major burden for many Americans. This analysis from KFF Health News examines various policy options being considered to address the issue. These include government price negotiations, capping out-of-pocket costs for seniors, and measures to increase competition from generic drugs. The article breaks down the potential impact of these policies on patients, pharmaceutical companies, and the healthcare system, highlighting the complex trade-offs involved in drug pricing reform.
